Exane Derivatives’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11
| Closed | -$799 | – | 887 |
|
|
2022
Q1 | $799 | Buy |
+11
| New | +$799 | ﹤0.01% | 819 |
|
|
2021
Q4 | – | Sell |
-11
| Closed | -$992 | – | 933 |
|
|
2021
Q3 | $992 | Hold |
11
| – | – | ﹤0.01% | 844 |
|
|
2021
Q2 | $963 | Hold |
11
| – | – | ﹤0.01% | 863 |
|
|
2021
Q1 | $1.25K | Hold |
11
| – | – | ﹤0.01% | 695 |
|
|
2020
Q4 | $1.52K | Hold |
11
| – | – | ﹤0.01% | 633 |
|
|
2020
Q3 | $904 | Hold |
11
| – | – | ﹤0.01% | 597 |
|
|
2020
Q2 | $860 | Hold |
11
| – | – | ﹤0.01% | 541 |
|
|
2020
Q1 | $489 | Hold |
11
| – | – | ﹤0.01% | 573 |
|
|
2019
Q4 | $671 | Hold |
11
| – | – | ﹤0.01% | 557 |
|
|
2019
Q3 | $470 | Hold |
11
| – | – | ﹤0.01% | 561 |
|
|
2019
Q2 | $698 | Sell |
11
-1,590
| -99% | -$101K | ﹤0.01% | 553 |
|
|
2019
Q1 | $111K | Buy |
1,601
+783
| +96% | +$54.3K | 0.02% | 273 |
|
|
2018
Q4 | $35.6K | Buy |
+818
| New | +$35.6K | 0.01% | 366 |
|